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ABSTRACT
Congenital adrenal hyperplasia IS an
autosomal recessive disease with a wide
range of clinical manifestations. Deficiency
of the 21-hydroxylase is the most common
form of congenital adrenal hyperplasia,
accounting for over 90% of cases. The aim
of the study is to detect the presence of
point mutations using specific probe P30L
in exon 1 of CYP21 gene. Point mutations
were studied using the PCR-ASOH Allele
Specific Oligonucleotide Hybridization)
technique with Digoxigenin (DIG) system.
The Pro30Leu(P30L) mutation is associated
with electrolyte disturbances was found in 2
patients out of 30 patients. The P30L
mutation might cause electrolyte
imbalances during neonatal periods that
subsequently normalize without hormonal
replacement therapy.
Key Words: Congenital adrenal hyperplasia, ASOH (Allele Specific
Oligonucleotide Hybridization).
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INT DUCTION
Deficiency of the 21- hydroxylase (21-0H) is the most
common form of congenital adrenal hyperplasia
(CAH), accounting for over 90% of cases. This
enzyme deficiency results in a reduced ability to
synthesize cortisol and aldosterone, leading to
increase secretion of adrenocorticotrophin (ACTH),
which causes hyperplasia of the adrenals and an
increase in androgens 2. Three different clinical
phenotypes is described: which includes the salt
wasting (SW), simple virilizing (SV) and the non
classical (NC) form. The 21-hydroxylase gene
(CYP21) is located in chromosome 6p 21.31.
Molecular diagnostic techniques rely on the
assumption that specific mutation of CYP21 gene
give rise to the same form of CAH expression. PCR-
Allele Specific Oligonucleotide Hybridization (PCR-
ASOH) method can be 'applied subsequently to
identify point mutations in the amplified CYP21
gene3 , with using specific probe Pr030Leu (P30L) to
detect in exon 1 of CYP21 gene. P30L mutations are
associated with the simple virilizing or non-classical
form of CAH.
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To detect the presence of point mutations
using specific probe P 30 L in exon 1 of CYP21
gene.
METHODOLOGY
73 blood samples were obtained from patients and thei!" families referred
to Hospital Universiti Sains Malaysia. Kelantan. A thorough clinical
examination and hormonal analyst's WHC performed. A total of 30
. samples included were suspected to haH CAH based on ambiguity of the
external genitalia or electrolyte imbahlllccs. The other samples were
obtained from parents and patients siblings wheneycr possible.
DNA extraction
(non-phenol chloroform standard procedure)
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Polymerase Chain Reaction(PCR)
PCR-ASOH (Allele Specific Oligonucleotide
Hybridization) technique with Digoxigenin (DIG)
system.
--------------
Presence of PCR product (873 bp) for CYP21 gene exon 1-3 using
2.0 % agarose gel electrophoresis (see figure 1).
Figure 1. Lane M is a 100 bp DNA ladder, lane N is negative control,lane 1,2, are
normal sample and lane 3,4,5,6 sample showed peR amplific8tion products for
CYP21 gene.
The presence of P30L mutations, which have been established to be the cause of
complete or partial 21- hydroxylase enzyme inactivation, was analyzed by PCR -
ASOH using DIG system in 30 patients with ambiguous genitalia as well as in 43
famliv members.
P1 F1 M1 P2 F2 M2
Figure 2:
Dot blotting was performed using 1~g genomic DNA. The blot was hybridized
with 100 pmol/ml of the digoxigenin labeled antiphosphatase (DIG-AP) specific
I
.'; ", probe P30L. ASOH of peR product from CAH patients or parents, with P30 L
~~':~~':. corresponding to the site exon 1 .The status P: Patient, M: Mother, F: father.
:~l~:
"'. ';'~";11';;.;; i.U~•• !, _ :i\:,.;}'.-
.~- :. : -::.
I ..
The Pro30Leu mutation is associated with electrolyte
disturbances was found in 2 patients out of 30 patients.
Patient I, fullterm delivered by emergency Caesarean
section due to bleeding placenta praevia. Baby was
admitted to the neonatal intensive care unit for transient
tachypnoea of the newborn. Examination of the genitalia
was normal male with both testes descended in the
scrotum. Initial electrolytes showed hyponatraemia and
hiperkalaemia with normal serum cortisol level. On follow-
up patient was gaining weight with normal electrolytes.
Patient II presented at the age of 2 months with
hyponatraemia and hyperkalaemia. There was a normal
male external genitalia with both testes descended. He was
~reated with sodium chloride and fJudrocortisone. In both
patients, there was no ambiguity of the external genitalia
and both have salt loss. However the salt loss only require
short term replacement therapy with sodium chloride and
fludrocortisone in patient II and no treatment in patient I.
We would like to hypothesize that P30L mutation might
cause electrolyte imbalances during neonatal period that
subsequently normalize without hormonal replacement
therapy. From the parents' results, we observe that P30L is
present in. the mother whereas P30L is present in one of
.;':, ..
;~ the fathers of both patients. We need to study more
.jt.: patients to be able to conclude a similar finding.
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